lesinurad 200 mg: Clinical Trials

3 completed. 3 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	3	Completed 3

Follow lesinurad 200 mg: new trials by email Literature Review of lesinurad 200 mg trials Research Report on lesinurad 200 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence. lesinurad/allopurinol 200/300 FDC tablets, lesinurad 200 mg, allopurinol 300 mg - Gout	Phase 1	Completed	Ardea Biosciences, Inc.	32	2017-08-14	2018-11-07
Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence lesinurad/allopurinol 200/300 FDC tablet, lesinurad 200 mg, allopurinol 300 mg - Healthy	Phase 1	Completed	Ardea Biosciences, Inc.	28	2016-08-30	2017-06-16
Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability lesinurad/allopurinol 200/300 FDC tablets, lesinurad 200 mg, allopurinol 300 mg - Healthy	Phase 1	Completed	Ardea Biosciences, Inc.	116	2015-10-01	2016-12-19

Conditions studied

Gout (1)

Sponsors

Ardea Biosciences, Inc. (3)

Countries

United States (2)  ·  Brazil (1)

Top investigators

N. Bhakta (3)